Cord Blood Platelet Lysate: In Vitro Evaluation to Support the Use in Regenerative Medicine

Caterina Giovanna Valentini, Eugenia Rosa Nuzzolo, Maria Bianchi, Nicoletta Orlando, Maria Grazia Iachininoto, Priscilla Pinci, Luciana Teofili

Research output: Contribution to journalArticlepeer-review


Platelet-rich plasma (PRP) is an inexpensive and safe substitute of recombinant growth factors in vitro and in vivo. Due to its putative effect on tissue repair, the use of autologous PRP has become largely popular. Recently, a jellified PRP derivative obtained from umbilical cord blood (CB) has been utilized in vivo to treat mucosal and cutaneous lesions. Nevertheless, whether PRP derived from CB and adult blood display different potency in promoting cell growth in vitro has been rarely investigated. In this study, we compared cytokine profile and mesenchymal cell growth supporting the ability of platelet lysate obtained from adult and cord blood. Our in vitro results strongly back the utilization of CB platelet lysate in vivo, as an efficacious, safe and inexpensive alternative to promote damaged tissue healing when the autologous PRP is contraindicated. Moreover, the policy of manufacturing CB platelet lysate can limit the current disposal of many collected CB units not suitable for transplant due to their low nucleated cell count.

Original languageEnglish
Pages (from-to)e2019021
JournalMediterranean Journal of Hematology and Infectious Diseases
Issue number1
Publication statusPublished - 2019


Dive into the research topics of 'Cord Blood Platelet Lysate: In Vitro Evaluation to Support the Use in Regenerative Medicine'. Together they form a unique fingerprint.

Cite this